Virginia Retirement Systems Et Al Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Virginia Retirement Systems Et Al

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	SELL	$144.95 - $152.29 $536,315 - $563,473	-3,700 Closed	0 $0
Q1 2022 Apr 21, 2022	SELL	$110.08 - $142.92 $319,232 - $414,467	-2,900 Reduced 43.94%	3,700 $439,000
Q4 2021 Feb 03, 2022	BUY	$99.73 - $148.48 $189,487 - $282,112	1,900 Added 40.43%	6,600 $910,000
Q3 2021 Oct 21, 2021	BUY	$98.85 - $138.91 $69,195 - $97,237	700 Added 17.5%	4,700 $653,000
Q2 2021 Aug 13, 2021	BUY	$65.78 - $105.02 $39,468 - $63,012	600 Added 17.65%	4,000 $388,000
Q1 2021 Apr 30, 2021	SELL	$64.07 - $91.75 $57,662 - $82,575	-900 Reduced 20.93%	3,400 $232,000
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $45,548 - $68,768	700 Added 19.44%	4,300 $369,000
Q3 2020 Nov 12, 2020	SELL	$59.04 - $77.95 $41,328 - $54,565	-700 Reduced 16.28%	3,600 $234,000
Q2 2020 Aug 12, 2020	BUY	$29.01 - $74.23 $124,743 - $319,189	4,300 New	4,300 $314,000
Q2 2019 Jul 26, 2019	SELL	$39.79 - $67.01 $604,808 - $1.02 Million	-15,200 Closed	0 $0
Q1 2019 Apr 25, 2019	BUY	$34.52 - $53.29 $524,704 - $810,008	15,200 New	15,200 $782,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.